TELO (Telomir Pharmaceuticals, Inc. Common Stock) Stock Analysis - Politician Trades
Telomir Pharmaceuticals, Inc. Common Stock (TELO) is a publicly traded Healthcare sector company. As of May 20, 2026, TELO trades at $1.26 with a market cap of $81.84M and a P/E ratio of 0.00. TELO moved +3.28% today. Year to date, TELO is -8.96%; over the trailing twelve months it is -51.97%. Its 52-week range spans $1.05 to $7.08. Rallies surfaces TELO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded TELO stock?
Rallies tracks politician and congressional stock disclosures for TELO, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Bay Shore Trust bought 49.00K (~$343.00K) on Feb 13, 2024.
TELO Analyst Consensus
TELO analyst coverage data. Average price target: $0.00.
Common questions about TELO
Which politicians traded TELO stock?
Rallies tracks politician and congressional stock disclosures for TELO, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in TELO?
Yes. Rallies tracks politician and congressional stock disclosures for TELO, including reported purchases, sales, dates, owners, and trade amounts when available.
Is TELO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for TELO. It does not provide personalized investment advice.